The United States Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial found no benefits from using prostate-specific antigen (PSA) screening for prostate cancer diagnoses [2]. The gene discussed is KLK3; the disease is ovarian carcinoma.